Abstract
Water-soluble prodrugs of potent, A(2A)-selective adenosine receptor
(AR) antagonists were prepared. 8-(m-Bromostyryl)-3, 7-dimethyl-1-propargylxanthine
(BS-DMPX, 11) and the analogous 8-(m-methoxystyryl)xanthine derivative
(MS-DMPX, 5b) were used as starting points. It was found that polar
functional groups suitable for the attachment of a prodrug moiety
were tolerated on the styryl ring and even better on the 3-substituent.
8-(m-Hydroxystyryl)-DMPX (7) and 3-(3-hydroxypropyl)-8-(m-methoxystyryl)-1-propargylxanthine
(5e, MSX-2) were the most potent and A(2A)-selective compounds and
were selected for prodrug formation. For the preparation of 5e a
new ring-closure method was applied. Treatment of 6-amino-1-(3-hydroxypropyl)-5-(m-methoxycinnamoylamino)-3-propa
rgylur acil with hexamethyldisilazane at high temperature resulted
in higher yields of the target xanthine than the standard ring-closure
procedure using sodium hydroxide. Phosphate prodrugs were prepared
by classical phosphorylation using phosphorus oxychloride and alternatively
by using a phosphoramidite method. Phosphates of the aliphatic alcohol
5e could be obtained by both methods in similar yields. The phenolic
compound 7, however, could be phosphorylated only by using the phosphoramidite
method. The disodium salts of the phosphate prodrugs exhibited high
water solubility (8-(m-methoxystyryl)-7-methyl-3-3-O-phosphatylpropyl-1-
propargylxan thine disodium salt, 9b: 17 mM, 9 mg/mL). Prodrug 9b
was found to be stable in aqueous solution (pH 7) but readily cleaved
by phosphatases to liberate 5e (MSX-2). Compound 5e showed high affinity
for rat A(2A) AR (K(i) = 8 nM), human recombinant A(2A) AR (K(i)
= 5 nM), and human native A(2A) AR (K(i) = 15 nM) and was highly
selective versus rat A(1) AR (110-fold), human recombinant A(2A)
AR (500-fold), human A(2B) AR (>2000-fold), and human A(3) AR (>2000-fold).
Users
Please
log in to take part in the discussion (add own reviews or comments).